NovaBay Pharmaceuticals, Inc. (NYSE American: NBY), to be renamed Stablecoin Development Corporation (NYSE American: SDEV), is an on-chain holding company focused on long-duration participation in protocol-aligned digital asset ecosystems. The Company's common stock is expected to begin trading on the NYSE American under the ticker symbol SDEV on April 3, 2026. In 2026, the Company completed a comprehensive realignment of its business, adopting a capital allocation approach focused on acquiring and holding economically productive digital assets that enable participation in open, decentralized financial networks. The Company's core business consists of the accumulation, holding, and deployment of operating digital assets for use within blockchain-based networks to support protocol-level services, including staking, governance participation, and related activities. The Company's initial focus is SKY, the protocol token of the decentralized Sky Protocol. In January 2026, the Company completed a ~$134 million private placement with R01 Fund LP, Framework Ventures, Tether Investments, and Sky Frontier Foundation, consisting of cash, stablecoins, and SKY tokens. The Company continues to deploy capital toward the acquisition of additional SKY tokens on the open market. Headquartered in Emeryville, California. Committed to prudent governance, regulatory compliance, and long-term shareholder value creation. For more information, visit www.novabay.com.
NovaBay Pharmaceuticals の市場拡大を追跡しています
NovaBay Pharmaceuticals の海外展開を競合と比較
NovaBay Pharmaceuticals自社バーは比較対象企業間の相対的な規模を示します。
列5| 企業 | 市場 | 新規市場 | モメンタム | アクティビティ | 拡大スコア |
|---|---|---|---|---|---|
 NovaBay Pharmaceuticals自社 | 0 | 0 | — | 0 | 0 |
現在採用していません
この企業をフォローして、変化があり次第通知を受け取るにはサインアップしてください。
実施中のキャンペーンはありません
この企業をフォローして、変化があり次第通知を受け取るにはサインアップしてください。
認証済みメールと直通電話を解放
無料 · カード不要
NovaBay Pharmaceuticals の事業、市場、成長シグナルに関する簡潔な回答。
© 2026 Pubrio. 無断転載を禁じます。
